title: Prospective evaluation of quality of surgery in soft tissue sarcoma.
abstract: BACKGROUND
  Prospective application of the French Sarcoma Group (FSG) method of surgery reporting in soft tissue sarcoma (STS) in a single centre.
  
  
  METHODS
  Patients with primary STS of the extremities or trunk wall consecutively operated at the same institution from January 1996 to December 2002 were evaluated for local recurrence (LR). There were 205 patients, with AJCC/UICC stages III and IV in 51% of cases. Resection types according to FSG were R0 in 147, R1 in 53 and R2 in five cases. Radiotherapy was delivered in 163 patients and chemotherapy in 103. Multivariate analysis was performed. Overall five-year survival was 75%. Median follow-up for surviving patients was 53 months.
  
  
  RESULTS
  Actuarial five-year LR incidence was 13% in 200 patients with gross resection (R0+R1), it was 7% in R0 and 30% in R1 patients (p<0.0001). At univariate analysis, significant prognosticators for LR were age, histotype, tumour invasion, grade and resection type R. At multivariate analysis, resection R1 (relative risk (RR) 4.3, p=0.001) and grade 3 (RR 3.9, p=0.013) independently predicted LR. Combining these two variables produced three prognostic groups for LR: group 0 (no factor, n=70), group 1 (one factor, n=94) and group 2 (two factors, n=36) with five-year LR of 4%, 12% and 39%, respectively (p=6.4x10(-7)).
  
  
  CONCLUSIONS
  This first prospective evaluation of surgery reporting in STS evidences a fourfold, highly discriminating difference in LR between resections R0 and R1.
authors.affiliation: Department of Surgery, Institut Bergonié, Regional Cancer Centre, 229 Cours de l'Argonne, 33076 Bordeaux Cedex, Bordeaux, France. stoeckle@bergonie.org
authors.forename: E
authors.initials: E
authors.lastname: Stoeckle
authors.forename: H
authors.initials: H
authors.lastname: Gardet
authors.forename: J-M
authors.initials: JM
authors.lastname: Coindre
authors.forename: G
authors.initials: G
authors.lastname: Kantor
authors.forename: F
authors.initials: F
authors.lastname: Bonichon
authors.forename: Y
authors.initials: Y
authors.lastname: Milbéo
authors.forename: L
authors.initials: L
authors.lastname: Thomas
authors.forename: A
authors.initials: A
authors.lastname: Avril
authors.forename: B N
authors.initials: BN
authors.lastname: Bui
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003131:Combined Modality Therapy; D005121:Extremities; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D018365:Neoplasm, Residual; D011379:Prognosis; D012307:Risk Factors; D012509:Sarcoma / Q000473:pathology / Q000601:surgery*; D012983:Soft Tissue Neoplasms / Q000473:pathology / Q000601:surgery*